Spark Biomedical Transcutaneous Auricular Neurostimulation for Opioid Withdrawal Relief
Overview
Spark Biomedical Inc is a company specializing in non-invasive neurostimulation solutions, headquartered in Dallas, Texas. The company develops neurostimulation technology aimed at addressing health challenges, particularly in the treatment of opioid withdrawal symptoms. Spark Biomedical's Sparrow Therapy System, which is FDA-cleared, represents their first-generation device designed to provide a safe and drug-free approach to managing withdrawal. The company has since introduced its second-generation device, Sparrow Ascent, which aims to further enhance treatment options for opioid addiction. Founded in 2018, Spark Biomedical focuses on evidence-based solutions and collaborates with healthcare providers and researchers to improve patient outcomes.
Details
- Category
- Medical Equipment Manufacturing
- Headquarters
- Dallas, Texas
- Type
- Privately Held
- Founded
- 2018
- Followers
- 6,695
- Specialties
- Medical Device, Neuromodulation, and Biotechnology
- Locations
- Dallas, Texas 75252, US
Funding
Total rounds: 7
Last round: Grant, Nov 20, 2025
Last round amount: US$ 305.0K
Similar companies
- https://brainpatch.ai/catalog/company/neurosoft-bioelectronics/855
- https://brainpatch.ai/catalog/company/flow-neuroscience-393668fe/561
- https://brainpatch.ai/catalog/company/motif-neurotech-e399c63a/329
- https://brainpatch.ai/catalog/company/precision-neuroscience-corporation/667
- https://brainpatch.ai/catalog/company/phantomneuro/1038